1. Home
  2. AMLX vs SCL Comparison

AMLX vs SCL Comparison

Compare AMLX & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$14.05

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Stepan Company

SCL

Stepan Company

HOLD

Current Price

$48.72

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMLX
SCL
Founded
2014
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
AMLX
SCL
Price
$14.05
$48.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
1
Target Price
$19.56
$75.00
AVG Volume (30 Days)
774.9K
159.2K
Earning Date
06-08-2026
05-27-2026
Dividend Yield
N/A
3.17%
EPS Growth
65.46
N/A
EPS
N/A
2.05
Revenue
$380,786,000.00
$1,803,737,000.00
Revenue This Year
N/A
$6.98
Revenue Next Year
N/A
$4.69
P/E Ratio
N/A
$24.24
Revenue Growth
1612.94
N/A
52 Week Low
$3.11
$41.82
52 Week High
$17.49
$68.00

Technical Indicators

Market Signals
Indicator
AMLX
SCL
Relative Strength Index (RSI) 46.84 30.44
Support Level $13.28 $47.21
Resistance Level $15.27 $51.10
Average True Range (ATR) 0.92 2.38
MACD -0.03 -1.78
Stochastic Oscillator 14.61 3.27

Price Performance

Historical Comparison
AMLX
SCL

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: